TWiV 1010: Clinical update with Dr. Daniel Griffin
This Week in Virology
00:00
The FDA Approves the Abris v Vaccine to Protect Infants From RSV
An advisory panel of the FDA voted in favor of approving the Abris V vaccine by Pfizer to prevent severe respiratory virus that is a potentially deadly threat to infants. The idea here is that an individual gets the vaccine in the last trimester of pregnancy, and the infants then have this robust protection during that most critical period of time.
Transcript
Play full episode
